Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: February 2020 (incorporating Half Yearly Report and Accounts)
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Key Financial Metrics
The provided filing text serves as a cover sheet and does not contain specific financial data. The document references the inclusion of a "Half Yearly Report and Accounts" but does not list values for revenue, profit, cash flow, margins, debt, or liquidity within this text.
Material Changes
No material changes or comparative financial data are detailed in the provided text. The filing indicates the incorporation of the half-yearly report by reference, but the specific content of that report is not included in the input.
Guidance, Outlook, and Risks
The text does not provide management commentary, future guidance, risk factors, contingencies, or details on unusual items. It confirms the report is being incorporated by reference into Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417).
Investor Verification Checklist
- Verify the full content of the "Half Yearly Report and Accounts" referenced in Item 99.1, as financial figures are not present in this cover document.
- Confirm the status of the Registration Statements on Form S-8 and Form F-3 into which this report is incorporated.
- Review the signed authorization by Geoffrey Kempler, Executive Chairman, dated February 27, 2020.